BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu P, Mao Y, Xie Y, Wei J, Yao J. Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential. Stem Cell Res Ther 2022;13:356. [PMID: 35883127 DOI: 10.1186/s13287-022-03041-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu P, Qian Y, Liu X, Zhu X, Zhang X, Lv Y, Xiang J. Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis. Front Immunol 2022;13:1096402. [PMID: 36685534 DOI: 10.3389/fimmu.2022.1096402] [Reference Citation Analysis]
2 Han J, Lee C, Hur J, Jung Y. Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease. Cells 2022;12. [PMID: 36611816 DOI: 10.3390/cells12010022] [Reference Citation Analysis]
3 Hu Y, Lan Y, Ran Q, Gan Q, Tang S, Huang W. Exploration of the Potential Targets and Molecular Mechanism of Carthamus tinctorius L. for Liver Fibrosis Based on Network Pharmacology and Molecular Docking Strategy. Processes 2022;10:1735. [DOI: 10.3390/pr10091735] [Reference Citation Analysis]